Erytech Pharma S.A. buy tbackenh
Start price
31.03.17
/
50%
€28.20
Target price
02.10.17
€32.00
Performance (%)
-17.59%
End price
02.10.17
€23.24
Summary
This prediction ended on 02.10.17 with a price of €23.24. The price of Erytech Pharma S.A. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -17.59%. tbackenh has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Erytech Pharma S.A. | - | - | - | - |
| iShares Core DAX® | -1,59 % | 5,03 % | 6,33 % | 64,06 % |
| iShares Nasdaq 100 | -4,15 % | -0,13 % | 25,73 % | 86,92 % |
| iShares Nikkei 225® | -6,30 % | 0,53 % | 41,38 % | 77,87 % |
| iShares S&P 500 | -3,23 % | 0,47 % | 20,45 % | 68,19 % |
Comments by tbackenh for this prediction
In the thread Erytech Pharma S.A. diskutieren
Erytech Pharma S.A.
Phase 2 eines Bauchspeicheldrüsenkrebsmedikamentes erfolgreich abgeschlossen, könnte 2017 richtig abgehen.
(Laufzeit überschritten)
Stopped prediction by tbackenh for Erytech Pharma S.A.
Erytech Pharma S.A.
Start price
Target price
Perf. (%)
€19.25
26.09.16
26.09.16
€22.00
27.03.17
27.03.17
-25.71%
27.03.17
27.03.17
